{"filings":[{"id":553156,"accession_number":"0001437749-26-017929","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2026-05-20T19:36:45+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"Radnostix extends Series C Preferred maturity to February 28, 2028","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Majority of Series C Preferred holders approved extension of maturity date by one year to February 28, 2028.","All other terms of the Series C Preferred Stock remain unchanged.","Company filed Certificate of Amendment with Texas Secretary of State on May 19, 2026."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":100538,"accession_number":"0001437749-26-008319","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2026-03-16T23:59:59+00:00","items":["1.02","8.01","9.01"],"status":"ready","headline":"Radnostix terminates $12.45M DUF6 plant sale to AFR; voluntary capsule recall","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["APA terminated mutually on March 11, 2026; AFR could not pay $12.45M balance by March 31, 2026.","AFR had paid $170K in non-refundable fees; no closing proceeds received by Radnostix.","Company sees asset appreciation, low buyer funding confidence; will evaluate DUF6 plant options.","Voluntary recall of Dibasic Sodium Phosphate Capsules (lots 2022-2025) for final capsule weight out of spec.","Estimated costs: $125K write-offs and refunds; further $75K inventory + $25K-$75K/week lost revenue thru Q2."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116854,"accession_number":"0001437749-25-039001","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-12-31T23:59:59+00:00","items":["5.03","8.01","9.01"],"status":"ready","headline":"International Isotopes changes name to Radnostix; ticker INIS unchanged","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Name changed from International Isotopes Inc. to Radnostix, Inc. effective December 23, 2025.","Board approved the change on October 21, 2025; shareholders consented on November 25, 2025.","Rebranding reflects expanded focus on radioisotopes and theranostics for healthcare applications.","Common stock continues trading under symbol INIS on OTCQB; no action required from shareholders."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116853,"accession_number":"0001437749-25-031242","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"International Isotopes enters CEO employment agreement, appoints Dr. Duke Fu as director, and amends bylaws","summary_kind":"llm","event_type":"leadership","confidence":"high","bullets":["CEO Shahe Bagerdjian signs new employment agreement with $314,000 base salary, 5% annual increases, and 37,500,000 RSUs vesting at share price milestones up to $0.30.","Dr. Duke W. Fu appointed to board and audit committee; receives 250,000 RSUs per annual term starting July 11, 2026.","Bylaws amended to add advance notice procedures for shareholder business and director nominations, and provisions for indemnification and insurance.","Bylaws now allow postponement of special meetings and shareholder action by less-than-unanimous written consent."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":116852,"accession_number":"0001437749-25-031241","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-10-17T23:59:59+00:00","items":["5.02","5.03","9.01"],"status":"ready","headline":"International Isotopes CEO Bagerdjian signs 5-year employment agreement; Dr. Fu appointed to board","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["CEO Shahe Bagerdjian's base salary set at $314K with automatic 5% annual increases through 2030 and up to $250K in milestone raises based on quarterly revenue hitting $3.75M–$25M.","Bagerdjian awarded 37.5M RSUs vesting in tranches at share prices of $0.10 to $0.30 over 60 consecutive calendar days; immediate vesting upon termination without cause or change of control.","Dr. Duke W. Fu, nuclear pharmacist executive, appointed to board and audit committee; receives 250K RSUs annually.","Bylaws amended: clarify special meeting business, add advance notice for shareholder proposals and director nominations, allow advisory directors, and update indemnification/insurance provisions."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"positive","materiality_score":0.6,"calibrated_materiality_score":0.6,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":133295,"accession_number":"0001437749-25-022820","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2025-07-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"International Isotopes shareholders approve reverse stock split, re-elect directors","summary_kind":"llm","event_type":"other_material","confidence":"high","bullets":["Shareholders approved amendment to certificate of formation for reverse stock split at ratio 1:50 to 1:275, with exact ratio set by Board.","All four director nominees elected: Robert Atcher, Shahe Bagerdjian, Christopher Grosso, Steve T. Laflin.","Ratification of Haynie & Company as independent auditor for FY2025, with ~324M votes for.","Advisory vote on executive compensation held every three years; 90.1% of votes cast in favor of triennial frequency.","Approx. 61.6% of outstanding shares represented at meeting, forming quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":186051,"accession_number":"0001437749-24-030450","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2024-10-02T23:59:59+00:00","items":["3.03","5.03","9.01"],"status":"ready","headline":"International Isotopes extends Series C Preferred maturity to Feb 28, 2027","summary_kind":"llm","event_type":"debt","confidence":"high","bullets":["Majority of Series C Preferred stockholders approved a two-year maturity extension to February 28, 2027.","All other terms of the Series C Convertible Redeemable Preferred Stock remain unchanged.","Certificate of Amendment filed with Texas Secretary of State on September 26, 2024.","Approval received on September 25, 2024; filing reported on Form 8-K dated September 26, 2024."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null},{"id":202654,"accession_number":"0001437749-24-022768","cik":1038277,"company_name":"RADNOSTIX INC","ticker":"INIS","form_type":"8-K","filed_at":"2024-07-16T23:59:59+00:00","items":["5.07"],"status":"ready","headline":"International Isotopes elects four directors, ratifies auditor at 2024 annual meeting","summary_kind":"llm","event_type":"other","confidence":"high","bullets":["Shareholders elected Robert Atcher, Shahe Bagerdjian, Christopher Grosso, and Steve T. Laflin as directors for one-year terms.","Haynie & Company ratified as independent auditor for fiscal year ending December 31, 2024 with 268,868,853 votes for, 107,440 against.","Approximately 269 million shares voted, representing 51.4% of outstanding shares, constituting a quorum."],"consensus_eps_estimate":null,"consensus_eps_actual":null,"consensus_revenue_estimate":null,"consensus_revenue_actual":null,"consensus_period":null,"consensus_source":null,"sentiment":"neutral","materiality_score":0.1,"calibrated_materiality_score":0.1,"market_cap_usd":41272168.80984952,"market_cap_bucket":"microcap","market_cap_source":"finnhub_profile2","market_cap_as_of_date":"2026-05-28","daily_digest_date":null,"daily_digest_url":null,"daily_digest_rank":null}],"next_cursor":null}